Skip to main content
Erschienen in: Inflammation 2/2024

12.12.2023 | RESEARCH

Microglial SLC25A28 Deficiency Ameliorates the Brain Injury After Intracerebral Hemorrhage in Mice by Restricting Aerobic Glycolysis

verfasst von: Ruili Han, Lei Liu, Yuying Wang, Ruolin Wu, Ying Yang, Yuanlin Zhao, Lele Jian, Yuan Yuan, Lijun Zhang, Yu Gu, Changjun Gao, Jing Ye

Erschienen in: Inflammation | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

The microglia overactivation-induced neuroinflammation is a significant cause of the brain injury after intracerebral hemorrhage (ICH). Iron homeostasis is crucial for microglia activation, but the mechanism and causality still need further study. This study aimed to explore the roles and mechanism of the mitochondrial iron transporter SLC25A28 in microglia activation after ICH. Intrastriatal injection of autologous blood was used to establish ICH model, and the neuroinflammation, iron metabolism and brain injuries were assessed in wildtype or microglia-specific SLC25A28 knockout mice after ICH. Mitochondria iron levels and microglial function were determined in SLC25A28 overexpressed or deleted microglia. The extracellular acidification rate (ECAR), lactate production, and glycolytic enzyme levels were used to determine aerobic glycolysis. The results showed that ICH stimulated mitochondrial iron overload, and synchronously upregulated the SLC25A28 expression. In vitro, SLC25A28 overexpression increased mitochondrial iron levels in microglia. Interestingly, microglial SLC25A28 deficiency ameliorated neuroinflammation, brain edema, blood–brain barrier injury and ethological alterations in mice after ICH. Mechanically, SLC25A28 deficiency inhibited microglial activation by restricting the aerobic glycolysis. Moreover, zinc protoporphyrin could reduce SLC25A28 expression and mitigated brain injury. SLC25A28 plays crucial roles in mitochondrial iron homeostasis and microglia activation after ICH, and it might be a potential therapeutic target for ICH.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Diseases, G.B.D., and C. Injuries. 2020. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 396 (10258): 1204–1222.CrossRef Diseases, G.B.D., and C. Injuries. 2020. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet 396 (10258): 1204–1222.CrossRef
2.
Zurück zum Zitat Xue, M., and V.W. Yong. 2020. Neuroinflammation in intracerebral haemorrhage: Immunotherapies with potential for translation. Lancet Neurology 19 (12): 1023–1032.CrossRefPubMed Xue, M., and V.W. Yong. 2020. Neuroinflammation in intracerebral haemorrhage: Immunotherapies with potential for translation. Lancet Neurology 19 (12): 1023–1032.CrossRefPubMed
3.
Zurück zum Zitat Bai, Q., M. Xue, and V.W. Yong. 2020. Microglia and macrophage phenotypes in intracerebral haemorrhage injury: Therapeutic opportunities. Brain 143 (5): 1297–1314.CrossRefPubMed Bai, Q., M. Xue, and V.W. Yong. 2020. Microglia and macrophage phenotypes in intracerebral haemorrhage injury: Therapeutic opportunities. Brain 143 (5): 1297–1314.CrossRefPubMed
4.
Zurück zum Zitat Urrutia, P.J., D.A. Borquez, and M.T. Nunez. 2021. Inflaming the brain with iron. Antioxidants (Basel) 10 (1). Urrutia, P.J., D.A. Borquez, and M.T. Nunez. 2021. Inflaming the brain with iron. Antioxidants (Basel) 10 (1).
5.
Zurück zum Zitat Nnah, I.C. and M. Wessling-Resnick. 2018. Brain iron homeostasis: a focus on microglial iron. Pharmaceuticals (Basel) 11 (4). Nnah, I.C. and M. Wessling-Resnick. 2018. Brain iron homeostasis: a focus on microglial iron. Pharmaceuticals (Basel) 11 (4).
6.
Zurück zum Zitat Sun, Y., et al. 2022. Ferroptosis and iron metabolism after intracerebral hemorrhage. Cells 12 (1). Sun, Y., et al. 2022. Ferroptosis and iron metabolism after intracerebral hemorrhage. Cells 12 (1).
7.
Zurück zum Zitat Nnah, I.C., C.H. Lee, and M. Wessling-Resnick. 2020. Iron potentiates microglial interleukin-1beta secretion induced by amyloid-beta. Journal of Neurochemistry 154 (2): 177–189.CrossRefPubMedPubMedCentral Nnah, I.C., C.H. Lee, and M. Wessling-Resnick. 2020. Iron potentiates microglial interleukin-1beta secretion induced by amyloid-beta. Journal of Neurochemistry 154 (2): 177–189.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Nakamura, K., et al. 2016. Activation of the NLRP3 inflammasome by cellular labile iron. Experimental Hematology 44 (2): 116–124.CrossRefPubMed Nakamura, K., et al. 2016. Activation of the NLRP3 inflammasome by cellular labile iron. Experimental Hematology 44 (2): 116–124.CrossRefPubMed
9.
Zurück zum Zitat Gan, Z.S., et al. 2017. Iron reduces M1 macrophage polarization in RAW264.7 macrophages associated with inhibition of STAT1. Mediators of inflammation 8570818. Gan, Z.S., et al. 2017. Iron reduces M1 macrophage polarization in RAW264.7 macrophages associated with inhibition of STAT1. Mediators of inflammation 8570818.
10.
Zurück zum Zitat Kenkhuis, B., et al. 2022. Iron accumulation induces oxidative stress, while depressing inflammatory polarization in human iPSC-derived microglia. Stem Cell Reports 17 (6): 1351–1365.CrossRefPubMedPubMedCentral Kenkhuis, B., et al. 2022. Iron accumulation induces oxidative stress, while depressing inflammatory polarization in human iPSC-derived microglia. Stem Cell Reports 17 (6): 1351–1365.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Ward, D.M., and S.M. Cloonan. 2019. Mitochondrial iron in human health and disease. Annual Review of Physiology 81: 453–482.CrossRefPubMed Ward, D.M., and S.M. Cloonan. 2019. Mitochondrial iron in human health and disease. Annual Review of Physiology 81: 453–482.CrossRefPubMed
13.
Zurück zum Zitat Li, Z., et al. 2021. Formyl peptide receptor 1 signaling potentiates inflammatory brain injury. Science Translational Medicine 13 (605). Li, Z., et al. 2021. Formyl peptide receptor 1 signaling potentiates inflammatory brain injury. Science Translational Medicine 13 (605).
14.
Zurück zum Zitat Wang, Y.C., et al. 2013. Toll-like receptor 4 antagonist attenuates intracerebral hemorrhage-induced brain injury. Stroke 44 (9): 2545–2552.CrossRefPubMed Wang, Y.C., et al. 2013. Toll-like receptor 4 antagonist attenuates intracerebral hemorrhage-induced brain injury. Stroke 44 (9): 2545–2552.CrossRefPubMed
15.
Zurück zum Zitat Minhas, P.S., et al. 2019. Macrophage de novo NAD(+) synthesis specifies immune function in aging and inflammation. Nature Immunology 20 (1): 50–63.CrossRefPubMed Minhas, P.S., et al. 2019. Macrophage de novo NAD(+) synthesis specifies immune function in aging and inflammation. Nature Immunology 20 (1): 50–63.CrossRefPubMed
16.
Zurück zum Zitat Perez de la Ossa, N., et al. 2010. Iron-related brain damage in patients with intracerebral hemorrhage. Stroke 41 (4): 810–813. Perez de la Ossa, N., et al. 2010. Iron-related brain damage in patients with intracerebral hemorrhage. Stroke 41 (4): 810–813.
17.
Zurück zum Zitat Sun, X.G., et al. 2022. Aerobic glycolysis induced by mTOR/HIF-1α promotes early brain injury after subarachnoid hemorrhage via activating M1 microglia. Translational Stroke Research. Sun, X.G., et al. 2022. Aerobic glycolysis induced by mTOR/HIF-1α promotes early brain injury after subarachnoid hemorrhage via activating M1 microglia. Translational Stroke Research.
18.
Zurück zum Zitat Cloonan, S.M., et al. 2016. Mitochondrial iron chelation ameliorates cigarette smoke-induced bronchitis and emphysema in mice. Nature Medicine 22 (2): 163–174.CrossRefPubMedPubMedCentral Cloonan, S.M., et al. 2016. Mitochondrial iron chelation ameliorates cigarette smoke-induced bronchitis and emphysema in mice. Nature Medicine 22 (2): 163–174.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Kase, C.S., and D.F. Hanley. 2021. Intracerebral Hemorrhage: Advances in emergency care. Neurologic Clinics 39 (2): 405–418.CrossRefPubMed Kase, C.S., and D.F. Hanley. 2021. Intracerebral Hemorrhage: Advances in emergency care. Neurologic Clinics 39 (2): 405–418.CrossRefPubMed
20.
Zurück zum Zitat Wilkinson, D.A., et al. 2018. Injury mechanisms in acute intracerebral hemorrhage. Neuropharmacology 134 (Pt B): 240–248.CrossRefPubMed Wilkinson, D.A., et al. 2018. Injury mechanisms in acute intracerebral hemorrhage. Neuropharmacology 134 (Pt B): 240–248.CrossRefPubMed
21.
Zurück zum Zitat Bulters, D., et al. 2018. Haemoglobin scavenging in intracranial bleeding: Biology and clinical implications. Nature Reviews Neurology 14 (7): 416–432. Bulters, D., et al. 2018. Haemoglobin scavenging in intracranial bleeding: Biology and clinical implications. Nature Reviews Neurology 14 (7): 416–432.
22.
Zurück zum Zitat Cronin, S.J.F., et al. 2019. The role of iron regulation in immunometabolism and immune-related disease. Frontiers in Molecular Biosciences 6: 116.CrossRefPubMedPubMedCentral Cronin, S.J.F., et al. 2019. The role of iron regulation in immunometabolism and immune-related disease. Frontiers in Molecular Biosciences 6: 116.CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Hu, X., et al. 2019. Iron-load exacerbates the severity of atherosclerosis via inducing inflammation and enhancing the glycolysis in macrophages. Journal of Cellular Physiology 234 (10): 18792–18800.CrossRefPubMed Hu, X., et al. 2019. Iron-load exacerbates the severity of atherosclerosis via inducing inflammation and enhancing the glycolysis in macrophages. Journal of Cellular Physiology 234 (10): 18792–18800.CrossRefPubMed
24.
Zurück zum Zitat Paul, B.T., et al. 2017. Mitochondria and iron: Current questions. Expert Review of Hematology 10 (1): 65–79.CrossRefPubMed Paul, B.T., et al. 2017. Mitochondria and iron: Current questions. Expert Review of Hematology 10 (1): 65–79.CrossRefPubMed
25.
Zurück zum Zitat Seguin, A., et al. 2020. The mitochondrial metal transporters mitoferrin1 and mitoferrin2 are required for liver regeneration and cell proliferation in mice. Journal of Biological Chemistry 295 (32): 11002–11020.CrossRefPubMedPubMedCentral Seguin, A., et al. 2020. The mitochondrial metal transporters mitoferrin1 and mitoferrin2 are required for liver regeneration and cell proliferation in mice. Journal of Biological Chemistry 295 (32): 11002–11020.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Rouault, T.A. 2016. Mitochondrial iron overload: Causes and consequences. Current Opinion in Genetics & Development 38: 31–37.CrossRef Rouault, T.A. 2016. Mitochondrial iron overload: Causes and consequences. Current Opinion in Genetics & Development 38: 31–37.CrossRef
27.
Zurück zum Zitat Cunnane, S.C., et al. 2020. Brain energy rescue: An emerging therapeutic concept for neurodegenerative disorders of ageing. Nature Reviews Drug Discovery 19 (9): 609–633. Cunnane, S.C., et al. 2020. Brain energy rescue: An emerging therapeutic concept for neurodegenerative disorders of ageing. Nature Reviews Drug Discovery 19 (9): 609–633.
28.
Zurück zum Zitat Orihuela, R., C.A. McPherson, and G.J. Harry. 2016. Microglial M1/M2 polarization and metabolic states. British Journal of Pharmacology 173 (4): 649–665.CrossRefPubMed Orihuela, R., C.A. McPherson, and G.J. Harry. 2016. Microglial M1/M2 polarization and metabolic states. British Journal of Pharmacology 173 (4): 649–665.CrossRefPubMed
29.
Zurück zum Zitat Bernier, L.P., E.M. York, and B.A. MacVicar. 2020. Immunometabolism in the brain: How metabolism shapes microglial function. Trends in Neurosciences 43 (11): 854–869.CrossRefPubMed Bernier, L.P., E.M. York, and B.A. MacVicar. 2020. Immunometabolism in the brain: How metabolism shapes microglial function. Trends in Neurosciences 43 (11): 854–869.CrossRefPubMed
30.
Zurück zum Zitat Ma, W.Y., et al. 2023. A breakdown of metabolic reprogramming in microglia induced by CKLF1 exacerbates immune tolerance in ischemic stroke. Journal of Neuroinflammation 20 (1): 97.CrossRefPubMedPubMedCentral Ma, W.Y., et al. 2023. A breakdown of metabolic reprogramming in microglia induced by CKLF1 exacerbates immune tolerance in ischemic stroke. Journal of Neuroinflammation 20 (1): 97.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Urrutia, P.J., et al. 2017. Cell death induced by mitochondrial complex I inhibition is mediated by Iron Regulatory Protein 1. Biochimica et Biophysica Acta, Molecular Basis of Disease 1863 (9): 2202–2209.CrossRefPubMed Urrutia, P.J., et al. 2017. Cell death induced by mitochondrial complex I inhibition is mediated by Iron Regulatory Protein 1. Biochimica et Biophysica Acta, Molecular Basis of Disease 1863 (9): 2202–2209.CrossRefPubMed
32.
Zurück zum Zitat Tavsan, Z., and H. Ayar Kayali. 2015. The variations of glycolysis and TCA cycle intermediate levels grown in iron and copper mediums of Trichoderma harzianum. Applied Biochemistry and Biotechnology 176 (1): 76–85. Tavsan, Z., and H. Ayar Kayali. 2015. The variations of glycolysis and TCA cycle intermediate levels grown in iron and copper mediums of Trichoderma harzianum. Applied Biochemistry and Biotechnology 176 (1): 76–85.
33.
Zurück zum Zitat Loboda, A., et al. 2016. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: An evolutionarily conserved mechanism. Cellular and Molecular Life Sciences 73 (17): 3221–3247.CrossRefPubMedPubMedCentral Loboda, A., et al. 2016. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: An evolutionarily conserved mechanism. Cellular and Molecular Life Sciences 73 (17): 3221–3247.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Campbell, N.K., H.K. Fitzgerald, and A. Dunne. 2021. Regulation of inflammation by the antioxidant haem oxygenase 1. Nature Reviews Immunology 21 (7): 411–425.CrossRefPubMed Campbell, N.K., H.K. Fitzgerald, and A. Dunne. 2021. Regulation of inflammation by the antioxidant haem oxygenase 1. Nature Reviews Immunology 21 (7): 411–425.CrossRefPubMed
35.
Zurück zum Zitat Schipper, H.M., et al. 2019. The sinister face of heme oxygenase-1 in brain aging and disease. Progress in Neurobiology 172: 40–70.CrossRefPubMed Schipper, H.M., et al. 2019. The sinister face of heme oxygenase-1 in brain aging and disease. Progress in Neurobiology 172: 40–70.CrossRefPubMed
36.
Zurück zum Zitat Zhang, Z., et al. 2017. Distinct role of heme oxygenase-1 in early- and late-stage intracerebral hemorrhage in 12-month-old mice. Journal of Cerebral Blood Flow and Metabolism 37 (1): 25–38.CrossRefPubMed Zhang, Z., et al. 2017. Distinct role of heme oxygenase-1 in early- and late-stage intracerebral hemorrhage in 12-month-old mice. Journal of Cerebral Blood Flow and Metabolism 37 (1): 25–38.CrossRefPubMed
37.
Zurück zum Zitat Fernandez-Mendivil, C., et al. 2021. Protective role of microglial HO-1 blockade in aging: Implication of iron metabolism. Redox Biology 38: 101789.CrossRefPubMed Fernandez-Mendivil, C., et al. 2021. Protective role of microglial HO-1 blockade in aging: Implication of iron metabolism. Redox Biology 38: 101789.CrossRefPubMed
Metadaten
Titel
Microglial SLC25A28 Deficiency Ameliorates the Brain Injury After Intracerebral Hemorrhage in Mice by Restricting Aerobic Glycolysis
verfasst von
Ruili Han
Lei Liu
Yuying Wang
Ruolin Wu
Ying Yang
Yuanlin Zhao
Lele Jian
Yuan Yuan
Lijun Zhang
Yu Gu
Changjun Gao
Jing Ye
Publikationsdatum
12.12.2023
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 2/2024
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-023-01931-1

Weitere Artikel der Ausgabe 2/2024

Inflammation 2/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei seelischem Stress sind Checkpoint-Hemmer weniger wirksam

03.06.2024 NSCLC Nachrichten

Wie stark Menschen mit fortgeschrittenem NSCLC von einer Therapie mit Immun-Checkpoint-Hemmern profitieren, hängt offenbar auch davon ab, wie sehr die Diagnose ihre psychische Verfassung erschüttert

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.